InventHelp Inventor Develops Redesigned Mobility Chair With Enhanced Features (AAT-4108)
PITTSBURGH, Nov. 19, 2018 /PRNewswire/ -- Inventors from Fayetteville, Ga., have developed the CONVERTIBLE CHAIR, a modified mobility device that provides comfort and versatility for the user.
"We were inspired by a former student who was paralyzed. We witnessed how difficult it was for this person to get around and achieve independence. We developed our invention to help disabled individuals and to make their lives a little easier," said the inventors. The CONVERTIBLE CHAIR offers convenience and versatility to disabled individuals. It enhances comfort and safety for a wheelchair user. This device allows a user to extend their reach, which will encourage independence and self-sufficiency. It also offers a user-friendly, easy-to-use design. Ultimately, it will provide peace of mind to users, as well as their caretakers.
The original design was submitted to the Atlanta office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 17-AAT-4108, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
Parenteral Drug Association, Inc. (PDA) and UK-based Euromed Communications today announced the publication of Industrial Pharmaceutical Microbiology: Quality Control. This 500-page book includes 20 chapters from 19 industry leaders in pharmaceutical...
Children of America® (COA), held a red-carpet Awards Gala at the 2024 Leadership Summit April 6th in New Jersey. The transformative event gathered company leaders to honor one of their own heroic teachers and recognize the exceptional individuals...
Evermore Cannabis Company, a leader in innovative cannabis cultivation and product development, is thrilled to announce its remarkable success at the first-ever Maryland Leaf Bowl, held on April 13th. Demonstrating excellence across multiple...
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children's Hospital of Philadelphia (CHOP) used state-of-the-art...
